Meena RK, Syed NA, Sheikh ZA, Guru FR, Mir MH, Banday SZ et al. Patterns of treatment and outcomes in epithelial ovarian cancer: A retrospective North Indian Single-Institution experience. JCO Global Oncol. 2022(8):e2200032.

Goff BA, Mandel LS, Melancon CH, Muntz HG. Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. JAMA. 2004;291(22):2705–12.

Article  CAS  PubMed  Google Scholar 

Ramamoorthy V, Rubens M, Saxena A, Bhatt C, Das S, Appunni S, et al. Prevalence and inpatient hospital outcomes of Malignancy-Related Ascites in the united States. Am J Hospice Palliat Medicine®. 2021;38(1):47–53.

Article  Google Scholar 

Rietveld MJA, Husson O, Vos MC, van de Poll-Franse LV, Ottevanger PB, Ezendam NPM. Presence of gastro-intestinal symptoms in ovarian cancer patients during survivorship: a cross-sectional study from the PROFILES registry. Support Care Cancer. 2019;27(6):2285–93.

Article  PubMed  Google Scholar 

Pitiyarachchi O, Friedlander M, Java JJ, Chan JK, Armstrong DK, Markman M, et al.What proportion of patients with stage 3 ovarian cancer are potentially cured following intraperitoneal chemotherapy? Analysis of the long term (≥10 years) survivors in NRG/GOG randomized clinical trials of intraperitoneal and intravenous chemotherapy in stage III ovarian cancer. Gynecologic Oncology. 2022;166(3):410-6.

Stukan M. Drainage of malignant ascites: patient selection and perspectives. Cancer Manag Res. 2017;9:115–30.

Article  PubMed  PubMed Central  Google Scholar 

Berger JM, Preusser M, Berghoff AS, Bergen ES. Malignant ascites: current therapy options and treatment prospects. Cancer Treat Rev. 2023;121.

Baldwin LA, Huang B, Miller RW, Tucker T, Goodrich ST, Podzielinski I, et al. Ten-year relative survival for epithelial ovarian cancer. Obstet Gynecol. 2012;120(3):612–8.

Article  PubMed  Google Scholar 

Crothers B, Baloch Z, Chandra A, Farahani S, Kurtycz D, Schmitt F. The international system for reporting serous fluid cytopathology: introduction and overview of diagnostic terminology and reporting. In: Chandra A, Crothers B, Kurtycz D, Schmitt F, editors. The international system for serous fluid cytopathology. Cham: Springer International Publishing; 2020. pp. 1–7.

Google Scholar 

Marth C, Abreu MH, Andersen KK, Aro KM, de Lurdes Batarda M, Boll D, et al. Real-life data on treatment and outcomes in advanced ovarian cancer: an observational, multinational cohort study (RESPONSE trial). Cancer. 2022;128(16):3080–9.

Article  CAS  PubMed  Google Scholar 

Ayantunde AA, Parsons SL. Pattern and prognostic factors in patients with malignant ascites: a retrospective study. Ann Oncol. 2007;18(5):945–9.

Article  CAS  PubMed  Google Scholar 

Nagamine K, Kondo J, Kaneshiro R, Tauchi-Nishi P, Terada K. Ovarian needle aspiration in the diagnosis and management of ovarian masses. J Gynecol Oncol. 2017;28(4):e40.

Article  PubMed  PubMed Central  Google Scholar 

Baransi S, Michaan N, Gortzak-Uzan L, Aizic A, Laskov I, Gamzu R, et al. The accuracy of Ascites cytology in diagnosis of advanced ovarian cancer in postmenopausal women prior to neoadjuvant chemotherapy. Menopause. 2020;27(7):771–5.

Article  PubMed  Google Scholar 

Ng JKM, Chow LH, Ngai AMY, Chan RCK, Lee JHS, Lee ALH, et al. Number needed to diagnose in malignant ascites: effects of volume, repeating collection, and primary malignancy on diagnostic performance in peritoneal fluid cytology. Acta Cytol. 2023;67(4):434–43.

Article  CAS  PubMed  Google Scholar 

Sangisetty SL, Miner TJ. Malignant ascites: A review of prognostic factors, pathophysiology and therapeutic measures. World J Gastrointest Surg. 2012;4(4):87–95.

Article  PubMed  PubMed Central  Google Scholar 

Kadono T, Ishiki H, Yokomichi N, Ito T, Maeda I, Hatano Y et al. Malignancy-related Ascites in palliative care units: prognostic factor analysis. BMJ Supportive Palliat Care. 2023:spcare–2023.

Lee CK, Pires de Miranda M, Ledermann JA, Ruiz de Elvira MC, Nelstrop AE, Lambert HE, et al. Outcome of epithelial ovarian cancer in women under 40 years of age treated with platinum-based chemotherapy. Eur J Cancer. 1999;35(5):727–32.

Article  CAS  PubMed  Google Scholar 

Pignata S, Cecere C, Du Bois S, Harter A, Heitz P. Treatment of recurrent ovarian cancer. Ann Oncol. 2017;28:viii51–6.

Article  CAS  PubMed  Google Scholar 

Davis A, Tinker AV, Friedlander M. Platinum resistant ovarian cancer: what is it, who to treat and how to measure benefit? Gynecol Oncol. 2014;133(3):624–31.

Article  CAS  PubMed  Google Scholar 

Schorge JO, McCann C, Del Carmen MG. Surgical debulking of ovarian cancer: what difference does it make? Rev Obstet Gynecol. 2010;3(3):111–7.

PubMed  PubMed Central  Google Scholar 

Asher V, Lee J, Bali A. Preoperative serum albumin is an independent prognostic predictor of survival in ovarian cancer. Med Oncol. 2012;29(3):2005–9.

Article  CAS  PubMed  Google Scholar 

Fujii T, Tokuda S, Nakazawa Y, Kurozumi S, Obayashi S, Yajima R, et al. Implications of low serum albumin as a prognostic factor of Long-term outcomes in patients with breast cancer. Vivo. 2020;34(4):2033–6.

Article  CAS  Google Scholar 

Viganó A, Bruera E, Jhangri GS, Newman SC, Fields AL, Suarez-Almazor ME. Clinical survival predictors in patients with advanced cancer. Arch Intern Med. 2000;160(6):861–8.

Article  PubMed  Google Scholar 

Kaneko H, Shimura K, Yoshida M, Matsumoto Y, Kobayashi T, Uchiyama H, et al. Serum albumin levels strongly predict survival outcome of elderly patients with diffuse large B-Cell lymphoma treated with Rituximab-Combined chemotherapy. Int J Hematol Oncol Stem Cell Res. 2022;16(1):1–8.

PubMed  PubMed Central  Google Scholar 

Kwok WC, Ho JCM, Tam TCC, Ip MSM, Lam DCL. Serum protein level as a predictor of therapeutic response and adverse effects associated with Afatinib use. J Thorac Disease. 2022;14(6):1880–9.

Article  Google Scholar 

Tang Q, Li X, Sun CR. Predictive value of serum albumin levels on cancer survival: a prospective cohort study. Front Oncol. 2024;14:1323192.

Article  PubMed  PubMed Central  Google Scholar 

Laky B, Janda M, Cleghorn G, Obermair A. Comparison of different nutritional assessments and body-composition measurements in detecting malnutrition among gynecologic cancer patients1. Am J Clin Nutr. 2008;87(6):1678–85.

Article  CAS  PubMed  Google Scholar 

Schaible UE, Kaufmann SH. Malnutrition and infection: complex mechanisms and global impacts. PLoS Med. 2007;4(5):e115.

Article  PubMed  PubMed Central  Google Scholar 

Fentahun N, Anteneh Y, Menber Y. Malnutrition in the outcome of wound healing at public hospitals in Bahir Dar City, Northwest Ethiopia: A prospective cohort study. J Nutr Metabolism. 2021;2021(1):8824951.

Google Scholar 

Moosazadeh M, Espahbodi F, Afshari M, Eslami A. Can CBC profile and liver function test predict chronic kidney disease among a normal population?? Int J Prev Med. 2023;14:2.

Article  PubMed  PubMed Central  Google Scholar 

Baretti M, Pulluri B, Tsai HL, Blackford AL, Wolfgang CL, Laheru D, et al. The significance of Ascites in patients with pancreatic ductal adenocarcinoma: A Case-Control study. Pancreas. 2019;48(4):585–9.

Article  PubMed  PubMed Central  Google Scholar 

Chiba M, Goto T, Sato W, Shibuya T, Takahashi K, Minami S, et al. Extremely late recurrence of ovarian carcinoma diagnosed by an endoscopic Ultrasound-guided Fine-needle biopsy. Intern Med. 2021;60(2):247–50.

Article  PubMed  Google Scholar 

Katre R, Morani AK, Prasad SR, Surabhi VR, Choudhary S, Sunnapwar A. Tumors and pseudotumors of the secondary müllerian system: review with emphasis on Cross-Sectional imaging findings. Am J Roentgenol. 2010;195(6):1452–9.

Article  Google Scholar 

Corr BR, Moroney M, Sheeder J, Eckhardt SG, Sawyer B, Behbakht K, et al. Survival and clinical outcomes of patients with ovarian cancer who were treated on phase 1 clinical trials. Cancer. 2020;126(19):4289–93.

Article  PubMed  Google Scholar 

Moujaess E, Fakhoury M, Assi T, Elias H, El Karak F, Ghosn M, et al. The therapeutic use of human albumin in cancer patients’ management. Crit Rev Oncol/Hematol. 2017;120:203–9.

Article  PubMed  Google Scholar 

Rozga J, Piątek T, Małkowski P. Human albumin: old, new, and emerging applications. Ann Transpl. 2013;18:205–17.

Article  CAS  Google Scholar 

Giannakeas V, Kotsopoulos J, Brooks JD, Cheung MC, Rosella L, Lipscombe L et al. Platelet count and survival after cancer. Cancers (Basel). 2022;14(3).

Stone RL, Nick AM, McNeish IA, Balkwill F, Han HD, Bottsford-Miller J, et al. Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med. 2012;366(7):610–8.

Article  CAS  PubMed